Royal Bank of Canada issued reports affecting Humana's stock valuation, which was subsequently reported by MarketScreener.
2 reports, 2 independent
Updated Thu 00:00
No new developments lately
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada issued reports affecting Humana's stock valuation, which was subsequently reported by MarketScreener.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.RBC raised Humana price target while Humana filed SEC reports.1 source
RBC reports influenced Humana's stock valuation, as tracked by MarketScreener.1 source
Keep exploring
The entities involved
-
Royal Bank of Canada
financial institution in Canada
- Royal Bank of Canada lifted its position in the Dimensional U.S. Small Cap ETF, while several other firms increased their holdings on October 13, 2026.
- Financial institutions made various moves on June 18, 2026, including TD Cowen lowering its price objective, Citigroup raising its target, and Royal Bank of Canada increasing its target price. Separately, Man Group reduced its stock holdings.
-
Humana
American managed health care company
Related events
- Royal Bank of Canada raised its target price on USA Compression Partners, LP on June 7, 2026.
- Humana rallied, contributing to a lift in the US stock market, while Donald Trump struck a controversial deal with Russia.
- Houlihan Lokey disclosed insider trading via SEC filing while Royal Bank of Canada increased its stake in the company's stock.
- Royal Bank of Canada raised its price target on CBS stock, concurrent with MarketBeat reporting the average rating for the company.
- RBC decreased target price and rating on fund (Q5908002), while TD Cowen restated its rating on shares.